Graft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation

Basit Öğe Kaydı
dc.authorid0000-0002-7129-5024
dc.authorid0000-0003-0128-6947
dc.authorid0000-0002-0476-5452
dc.authorid0000-0001-8489-7449
dc.contributor.authorYaman, Yöntem
dc.contributor.authorBaysoy, Gökhan
dc.contributor.authorKeleşoğlu, Emre
dc.contributor.authorÖzdilli, Kürşat
dc.contributor.authorÇakır, Aslı
dc.contributor.authorGenç, Dildar Bahar
dc.contributor.authorElli, Murat
dc.contributor.authorAnak, Sema
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:49:48Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:49:48Z
dc.date.issued2019
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Tıbbi Patoloji Ana Bilim Dalı
dc.descriptionWOS: 000463814000008
dc.descriptionPubMed ID: 31061639
dc.description.abstractIn the pediatric population, hematopoietic stem cell transplantation (HSCT) is used to treat a wide variety of diseases, both malignant and nonmalignant. For many of these diseases, HSCT is a well-established treatment. Acute graft-versus-host disease (GVHD) continues to be a leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Graft versus host disease is a common complication of allo-SCT which is induced by donor T cell recognition of recipient alloantigens. The occurrence of autologous GVHD suggests that inappropriate recognition of host self-antigens may occur. GVHD in patients who received autologous HSCT is extremely rare compared to patients who received allogeneic HSCT. We present the case of a 4-year-old girl with metastatic neuroblastoma who spontaneously developed autologous GVHD after autologous HSCT.
dc.identifier.citationYaman, Y., Baysoy, G., Keleşoğlu, E., Özdilli, K., Erdoğan Çakır, A., Genç, D. B. ... Anak, S. (2019). Graft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation. Wspolczesna Onkologia-Contemporary Oncology, 23(1), 59-62. https://dx.doi.org/10.5114/wo.2019.83815
dc.identifier.doi10.5114/wo.2019.83815
dc.identifier.endpage62
dc.identifier.issn1428-2526
dc.identifier.issn1897-4309
dc.identifier.issue1
dc.identifier.scopusqualityQ3
dc.identifier.startpage59
dc.identifier.urihttps://dx.doi.org/10.5114/wo.2019.83815
dc.identifier.urihttps://hdl.handle.net/20.500.12511/1767
dc.identifier.volume23
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTermedia Publishing House Ltd
dc.relation.ispartofWspolczesna Onkologia-Contemporary Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGraft-Versus-Host Disease
dc.subjectChild
dc.subjectNeuroblastoma
dc.subjectAutologous Stem Cell Transplantation
dc.titleGraft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Yaman, Yöntem.pdf
Boyut:
127.59 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu